COMMUNIQUÉ DE PRESSE publié le 26/02/2024 à 14:00, il y a 6 mois 22 jours FSD Pharma Signs Agreement With Ingenu CRO to Conduct a Clinical Trial To Determine the Safety and Efficacy Effects of its Proprietary Blend Beverage unbuzzd(TM) FSD Pharma Inc. announced an agreement for a clinical trial to test unbuzzd™ effects on faster alcohol metabolism. The trial aims to confirm the supplement's potential benefits in sobering up from alcohol intoxication FSD Pharma Inc. Biopharmaceutical Clinical Trial Unbuzzd™ Alcohol Metabolism
BRÈVE publiée le 26/02/2024 à 14:00, il y a 6 mois 22 jours FSD Pharma launches a clinical trial to test the effectiveness of unbuzzd™ FSD Pharma Clinical Test Unbuzzd™ Alcohol Metabolism Accelerated Sobriety
BRÈVE publiée le 26/02/2024 à 14:00, il y a 6 mois 22 jours FSD Pharma lance un essai clinique pour tester l'efficacité d'unbuzzd™ FSD Pharma Essai Clinique Unbuzzd™ Métabolisme De L'alcool Sobriété Accélérée
COMMUNIQUÉ DE PRESSE publié le 17/02/2024 à 01:10, il y a 7 mois 3 jours FSD Pharma Announces US ATM Offering FSD Pharma announces an at-the-market offering agreement with H.C. Wainwright & Co., LLC to sell Class B Shares for up to US$11,154,232. The Company may use proceeds for clinical trials & general corporate purposes FSD Pharma Biopharmaceutical At-the-market Offering H.C. Wainwright & Co. Class B Shares
COMMUNIQUÉ DE PRESSE publié le 06/02/2024 à 13:00, il y a 7 mois 13 jours Court of Appeal Dismisses Motion for Leave to Appeal Brought by Dr. Raza Bokhari, FSD Pharma Awards Total Approximately $3 Million FSD Pharma Inc. announced that the Court of Appeal for Ontario affirmed the Judgment entered by the Superior Court of Justice. The company also filed a Petition to Confirm Arbitration Awards in the United States District Court for the Eastern District of Pennsylvania FSD Pharma Inc. Court Of Appeal Biopharmaceutical Arbitration Awards Neurodegenerative Disorders
COMMUNIQUÉ DE PRESSE publié le 29/01/2024 à 22:30, il y a 7 mois 21 jours FSD Pharma Announces Dr. Sanjiv Chopra is elected to FSD Pharma Board of Directors and Corporate Updates FSD Pharma appoints Dr. Sanjiv Chopra to its board of directors, replaces Nitin Kaushal. Also, the company retains SBS Intl Group LLC, Draper Inc., Carriage House Capital, Corp., IR Agency, Beyond Media, Issuer Direct for various services. FSD focuses on biopharmaceutical assets FSD Pharma Dr. Sanjiv Chopra Biopharmaceutical SBS Intl Group LLC IR Agency
COMMUNIQUÉ DE PRESSE publié le 16/01/2024 à 13:30, il y a 8 mois 3 jours Update Provided on GBB Drink Lab, Inc. Litigation and Safety Shot FSD Pharma Inc., a biopharmaceutical company, provides an update on its litigation with GBB Drink Lab, Inc., denying allegations and moving for discovery. The company remains confident in its legal position and looks forward to vindicating its rights and exposing GBB and its bully tactics. Biopharmaceutical Company FSD Pharma Inc. Litigation Update GBB Drink Lab Inc. Alcohol Detoxification
COMMUNIQUÉ DE PRESSE publié le 23/12/2023 à 01:45, il y a 8 mois 28 jours FSD Pharma Files Final Base Shelf Prospectus to Replace Expired Base Shelf Prospectus and Form F-3 Registration Statement with the SEC
COMMUNIQUÉ DE PRESSE publié le 05/12/2023 à 15:00, il y a 9 mois 14 jours FSD Pharma Inc. Announces Closing of Private Placement FSD Pharma Inc. announces the closing of private placement and issuance of class A multiple voting shares at $1.90 per share for gross proceeds of $45.60. The proceeds will be used for general working capital purposes Private Placement FSD Pharma Inc. Financial News Investment Class A Multiple Voting Shares
COMMUNIQUÉ DE PRESSE publié le 30/11/2023 à 14:30, il y a 9 mois 19 jours FSD Pharma Inc. and Celly Nutrition Corp. Announce Completion of Plan of Arrangement FSD Pharma Inc. and Celly Nutrition Corp. announce completion of Plan of Arrangement including distribution of Celly Nu Shares and New FSD Pharma Securities to FSD Pharma securityholders FSD Pharma Inc. Plan Of Arrangement Celly Nutrition Corp. Celly Nu Shares New FSD Pharma Securities
Publié le 19/09/2024 à 17:45, il y a 8 heures 23 minutes Gimv draagt helft van participatie in Infravest over aan WorxInvest (communicatie in toepassing van artikel 7:97 WVV)
Publié le 19/09/2024 à 17:45, il y a 8 heures 23 minutes Gimv sells half of participation in Infravest to WorxInvest (communication pursuant to article 7:97 BCAC)
Publié le 19/09/2024 à 17:45, il y a 8 heures 23 minutes Gimv sells half of participation in Infravest to WorxInvest (communication pursuant to article 7:97 BCAC)
Publié le 19/09/2024 à 23:15, il y a 2 heures 53 minutes Cypher Metaverse Inc. Announces Second Closing of Financing
Publié le 19/09/2024 à 23:00, il y a 3 heures 8 minutes WestJet Partners with FLYHT and NOAA to Improve Weather Forecasting in North America
Publié le 19/09/2024 à 23:00, il y a 3 heures 8 minutes Cerrado Files NI 43-101 Preliminary Economic Assessment Technical Report and Mineral Resource Estimate for The Minera Don Nicolas Mine in Santa Cruz, Argentina
Publié le 19/09/2024 à 21:09, il y a 4 heures 58 minutes EQS-Adhoc: Mercedes-Benz Group AG adjusts full-year guidance for the year 2024 based on current market outlook
Publié le 19/09/2024 à 18:44, il y a 7 heures 24 minutes Fuller, Smith & Turner PLC: Transaction in own shares
Publié le 19/09/2024 à 18:03, il y a 8 heures 5 minutes Funding Circle Plc: POS-Transaction in Own Shares
Publié le 19/09/2024 à 17:52, il y a 8 heures 15 minutes PILOT 28 : FIGEAC AÉRO remporte 3 nouveaux contrats sur l'A320 pour 65 millions d'euros
Publié le 19/09/2024 à 17:52, il y a 8 heures 15 minutes PILOT 28: FIGEAC AÉRO secures 3 new wins on the A320 airframe for 65 million euros